---
title: 'Blood lead levels and multiple sclerosis: A case-control study'
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-KRSXHGAF" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Dehghanifiroozabadi, M., Noferesti, P., Amirabadizadeh, A., Nakhaee, S., Aaseth, J., Noorbakhsh, F., &#38; Mehrpour, O. (2019). Blood lead levels and multiple sclerosis: A case-control study. <i>Multiple Sclerosis and Related Disorders</i>, <i>27</i>, 151–155. <a href="https://doi.org/10.1016/j.msard.2018.10.010">https://doi.org/10.1016/j.msard.2018.10.010</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-KRSXHGAF" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1627922" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/KRSXHGAF" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-KRSXHGAF" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-KRSXHGAF" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-KRSXHGAF" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://doi.org/10.1016/j.msard.2018.10.010" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://doi.org/10.1016/j.msard.2018.10.010" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-KRSXHGAF"></div>
</article>
<div id="csl-bib-meta-KRSXHGAF" class="csl-bib-meta">
  <article id="about-article-KRSXHGAF" class="about_pub-article">
    <h1>Om</h1>
    Dehghanifiroozabadi et al. gjennomførte ein studie for å undersøke samanhengen mellom blynivå i blod og multippel sklerose (MS), ein sjukdom som påverkar sentralnervesystemet. Dei samanlikna blynivå i blodet hos 29 MS-pasientar med nivåa hos 29 friske individ som var matchet etter alder, yrke og kjønn. Studien fann at MS-pasientane hadde signifikant høgare blynivå i blodet enn dei friske kontrollane. Spesielt auka risikoen for å utvikle MS med 1,17 gonger for kvar einings auke i blynivået i blodet. Dette tyder på at høgare eksponering for bly kan vere knytt til ein større sannsyn for å utvikle MS, og understrekar viktigheita av å overvake og handtere blyeksponering for potensielt å redusere risikoen for denne svekkande sjukdommen.
  </article>
  <article id="keywords-article-KRSXHGAF" class="keywords-article">
    <h1>Emneord</h1>
    Multippel sklerose, Blynivå i blod, Tungmetall, Sentralnervesystemet, Demyelinisering
  </article>
  <article id="abstract-article-KRSXHGAF" class="abstract-article">
    <h1>Samandrag</h1>
    Background 
Multiple sclerosis (MS) is a debilitating disease of the central nervous system, with disseminating demyelination of nerve fibers and spinal cord. Exposure to heavy metals seems to be associated with a higher incidence of MS. Few studies have assessed the correlation of the incidence of MS with heavy metal concentrations. The present study aimed to assess the relationship between blood lead levels and MS. 
 
Methods 
This case-control study was conducted on 29 MS patients and 29 healthy control persons. The controls were age, gender and occupation matched at the time of blood sampling. Blood lead levels were measured using the atomic absorption spectrometry method. Data were analyzed using Student t-test, Mann-Whitney U, and multiple logistic regression, using a significance level of p ˂ 0.05. 
 
Results 
According to the result of this study, the mean blood lead level (BLL) was 75.6 ± 9.35and33.8 ± 28.8 µg/L in patients with MS and control group, respectively. Median blood lead levels were significantly higher in MS patients (38 µg/L, range: 27–67), compared to the controls (30 µg/L, range: 11–49) (p = 0.03). The risk of MS increased 1.17 times per one µg/L increment of blood lead level, using the multiple logistic regression analysis on the present results. 
 
Conclusion 
In conclusion, based on our results, BLL was higher in MS patients, compared with healthy individuals. The risk of MS increased 1.17 times per one µg/L increment of blood lead level.
  </article>
  <article id="sdg-article-KRSXHGAF" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="/nn/archive/?key=?sdg=3#archive" class="sdg-publication-count"><span>1358</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-KRSXHGAF" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li>
        <a href="/nn/archive/?key=3DCRN523">Universitetet i Innlandet</a>
      </li>
      <li>
        <a href="/nn/archive/?key=IDKFS3MX">Fakultet for helse- og sosialvitenskap</a>
      </li>
      <li>
        <a href="/nn/archive/?key=GTV4ECMZ">Institutt for helse- og sykepleievitenskap</a>
      </li>
      <li>
        <a href="/nn/archive/?key=676HMQBA">2018</a>
      </li>
      <li>
        <a href="/nn/archive/?key=QBYYL8BM">November</a>
      </li>
    </ul>
  </article>
</div>
